|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/113 | |
| C12N 15/88 | |||
| A61K 31/712 | |||
| A61K 31/713 | |||
| A61K 9/127 | |||
| A61P 35/00 |
| (11) | Number of the document | 2279254 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09731866.1 |
| Date of filing the European patent application | 2009-04-15 | |
| (97) | Date of publication of the European application | 2011-02-02 |
| (45) | Date of publication and mention of the grant of the patent | 2017-07-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CA2009/000496 |
| Date | 2009-04-15 |
| (87) | Number | WO 2009/127060 |
| Date | 2009-10-22 |
| (30) | Number | Date | Country code |
| 45228 P | 2008-04-15 | US |
| (72) |
MACLACHLAN, Ian, CA
YAWORSKI, Edward, CA
LAM, Kieu, CA
JEFFS, Lloyd B., CA
PALMER, Lorne R., CA
|
| (73) |
Protiva Biotherapeutics Inc.,
100-8900 Glenlyon Parkway, Burnaby, British Columbia V5J 5J8,
CA
|
| (54) | NOVEL LIPID FORMULATIONS FOR NUCLEIC ACID DELIVERY |
| NOVEL LIPID FORMULATIONS FOR NUCLEIC ACID DELIVERY |